Hippo
-
InsurTechs, including Lemonade, Root, Hippo, and Metromile, shed some short interest but remain the target of choice for short-sellers.
-
The partnership should allow Hippo to expand its commercial lines HOA product into new markets.
-
Lemonade, Root, and Metromile remain the focus of short sellers, as most firms see little short interest change.
-
Lemonade and Root remain the focal points of short sellers, while Metromile’s stock loan fee rate increases (pending acquisition).
-
The Week in Brief: FM Global’s vaccine mandate, Hippo on going public, Hagerty SPAC deal redemptionsInside P&C’s news team runs you quickly through the key developments from the last week.
-
Richard McCathron said that Metromile’s fate does not concern him because InsurTechs are not made equal.
-
Just over a quarter of shareholders voted to redeem shares as Aldel Financial took classic car underwriter public.
-
Short interest fell in InsurTechs, but not enough to ease the pressure on the sector.
-
Everyone knows the phrase “A jack of all trades is a master of none.” Relatively few people know the continuation of the phrase: “but often times better than a master of one.”
-
Hippo execs showed confidence in the company as the InsurTech diversifies geographically with 63% of new homeowners' premium growing outside California and Texas.
-
The InsurTech lowered its LR to 128%, helped by cutting the contribution of cats to the loss ratio from 75% to 50%.
-
Root and Lemonade remain the highest-shorted stocks covered, as short interest in most firms remains flat in anticipation of earnings.